Selected References:
- Alwan S, et al. 2005. Angiotensin II receptor antagonist treatment during pregnancy. Birth Defects Res A Clin Mol Teratol. 73:123-130.
- Bass JK, Faix RG. 2006. Gestational Therapy with an Angiotensin II Receptor Antagonist and Transient Renal Failure in a Premature Infant. Am J Perinatol. 23:313-318.
- Daikha-Dahmane F, et al. 2006. Foetal kidney maldevelopment in maternal use of angiotensin II type I receptor antagonists. Pediatr Nephrol. 21(5):729-32.
- Diav-Citrin O, et al. 2011. Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers. Reprod Toxicol. 31(4):540-545.
- Gersak K, et al. 2009. Angiotensin II receptor blockers in pregnancy: a report of 5 cases. Reprod Toxicol. 28(1):109-12.
- Lambot M, et al. 2001. Angiotensin-II-receptor inhibitors in pregnancy. Lancet. 357:1619-1620.
- Marin EC, et al. 2014. The role of oxidative stress in renal injury induced in rats by losartan exposure during lactation. J Renin Angiotensin Aldosterone Syst. 15(4): 362-377.
- Martinovic J, et al. 2001. Fetal toxic effects and angiotensin-II-receptor antagonists. Lancet. 358:241-242.
- Saji H, et al. 2001. Losartan and fetal toxic effects. Lancet. 357:363.
- Schaefer C. 2003. Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity. Birth Defects Res Part A Clin Mol Teratol. 67:591-594.
- Serreau R, et al. 2005. Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of 10 cases. BJOG. 112(6):710-712.
- Sica DA, et al. 2005. Clinical pharmacokinetics of losartan. Clin Pharmacokinet. 44(8):797-814.
- Spaggiari E, et al. 2012. Renin-Angiotensin System Blockers Study Group, Muller F. Prognosis and outcome of pregnancies exposed to renin-angiotensin system blockers. Prenat Diagn. 18:1-6.
- Spence SG, et al. 1995. Evaluation of the reproductive and developmental toxicity of the AT1-selective angiotensin II receptor antagonist losartan in rats. Teratology. 51:383-97.
- Stevenson KM, et al. 1996. Effects of losartan on the cardiovascular system, renal haemodynamics and function and lung liquid flow in fetal sheep. Clin Exp Pharmacol Physiol. 23:125-33.
- Wei Q, et al. 2021. Use of angiotensin II receptor blocker during pregnancy: A case report. Medicine (Baltimore). 22;100(3):e24304.
